ClinicalTrials.gov
public full text
Public Domain
Stem Cell Therapy for Chronic Kidney Disease
chronic-kidney-diseasesdiabetes-mellitusdiabetic-kidney-diseasediabetic-nephropathykidneytype-1type-2
The purpose of this study is to assess the safety and tolerability of allogeneic mesenchymal stem / stromal cell therapy in individuals with chronic kidney disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease#1073365
- Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery#1407199
- Cell-based Therapy for the Treatment of Kidney Disease#881245
- Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal Transplant#279642
- Allogeneic Mesenchymal Stem Cells in Osteoarthritis#1058490
Record · ID 1418584
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive